Clinical Trials Directory

Trials / Unknown

UnknownNCT03926000

Pregabalin Premedication for Knee Arthroscopy

The Effect of Pregabalin Premedication on Anaesthetic Requirements and Recovery Time After Knee Arthroscopy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Outpatient arthroscopic knee surgery can be performed with general or regional anesthesia. Recent data suggest that spinal and epidural anesthesia require longer discharge times than the newer shorter-acting general anesthetic drugs. Ideal premedication drug should relieve anxiety, produce amnesia and sedation, decrease secretions, prevent nausea and vomiting, have dose sparing effect on the anaesthetic drugs, and suppress pressor response to laryngoscopy and intubation. Recently, gabapentin and pregabalin were suggested as pre-operative drugs to decrease anxiety, stress response to laryngoscopy and post operative pain.

Detailed description

112 patients undergoing elective knee arthroscopy will randomly divided into two equal groups, 56 patients each. All patients will receive premedication one hour before the procedure. PG group will receive 150 mg pregabalin and C group will receive placebo. All patients will receive total intravenous anesthesia to achieve optimum working conditions. Intra-operative total amount of anesthetics will be compared in both groups.

Conditions

Interventions

TypeNameDescription
DRUGPregabalin (PG)Pregabalin 150 mg one hour before the procedure as premedication.
DRUGControl placebo (C)Placebo tablets one hour before the procedure as premedication.

Timeline

Start date
2019-06-01
Primary completion
2019-11-01
Completion
2019-12-01
First posted
2019-04-24
Last updated
2019-04-25

Source: ClinicalTrials.gov record NCT03926000. Inclusion in this directory is not an endorsement.